National Institute of Neurological Disorders and Stroke, Interagency Pain Research Coordinating Committee Call for Committee Membership Nominations, 86830 [2024-25241]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
86830
Federal Register / Vol. 89, No. 211 / Thursday, October 31, 2024 / Notices
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Maria Dolores Arjona
Mayor, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 806D, Bethesda, MD 20892, (301) 827–
8578, dolores.arjonamayor@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
Investigation of Co-Occurring Conditions
Across the Lifespan to Understand Down
Syndrome.
Date: November 22, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health
Rockledge II 6701 Rockledge Drive Bethesda,
MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Katherine M Malinda,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4140,
MSC 7814, Bethesda, MD 20892, (301) 435–
0912, malindakm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–23–
199: ClinGen Genomic Curation Expert
Panels (U24).
Date: November 25, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge, Drive
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Altaf Ahmad Dar, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 827–2680,
altaf.dar@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neurotoxicology and Alcohol.
Date: November 25, 2024.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Alexei Kondratyev, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5200,
MSC 7846, Bethesda, MD 20892, 301–435–
1785, kondratyevad@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 25, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–25335 Filed 10–30–24; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:18 Oct 30, 2024
Jkt 265001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke, Interagency Pain
Research Coordinating Committee Call
for Committee Membership
Nominations
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The Department of Health and
Human Services (HHS) (Department)
has created the Interagency Pain
Research Coordinating Committee
(IPRCC) and is seeking nominations for
this committee.
DATES: Nominations are due by 5:00
p.m. ET on December 17, 2024.
ADDRESSES: Nominations must be
submitted through the webform on the
IPRCC website: https://
www.surveymonkey.com/r/IPRCCnomination-form.
FOR FURTHER INFORMATION CONTACT:
Leah Pogorzala, leah.pogorzala@nih.gov
or 301–496–4228.
SUPPLEMENTARY INFORMATION: As
specified in Public Law 111–148
(‘‘Patient Protection and Affordable Care
Act’’) the Committee will:
(A) develop a summary of advances in
pain care research supported or
conducted by the Federal agencies
relevant to the diagnosis, prevention,
and treatment of pain and diseases and
disorders associated with pain;
(B) identify critical gaps in basic and
clinical research on the symptoms and
causes of pain;
(C) make recommendations to ensure
that the activities of the National
Institutes of Health and other Federal
agencies are free of unnecessary
duplication of effort;
(D) make recommendations on how
best to disseminate information on pain
care; and (e) make recommendations on
how to expand partnerships between
public entities and private entities to
expand collaborative, cross-cutting
research.
Membership on the committee will
include six (6) non-Federal members
from among scientists, physicians, and
other health professionals and six (6)
non-Federal members of the general
public who are representatives of
leading research, advocacy, and service
organizations for individuals with painrelated conditions. Members will serve
overlapping three year terms. It is
anticipated that the committee will meet
at least once a year.
SUMMARY:
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
The Department strives to ensure that
the membership of HHS Federal
advisory committees is fairly balanced
in terms of points of view represented
and the committee’s function. Every
effort is made to ensure that the views
of diverse ethnic and racial groups and
people with disabilities are represented
on HHS Federal advisory committees,
and the Department therefore,
encourages nominations of qualified
candidates from these groups. The
Department also encourages geographic
diversity in the composition of the
Committee. Appointment to this
Committee shall be made without
discrimination on the basis of age, race,
ethnicity, gender, sexual orientation,
disability, and cultural, religious, or
socioeconomic status.
The Department is soliciting
nominations for non-federal members
from among scientists, physicians, and
other health professionals and for nonfederal members of the public who
represent a leading research, advocacy,
or service organization for people with
pain-related conditions. These
candidates will be considered to fill
positions opened through completion of
current member terms. Nominations are
due by 5:00 p.m. ET on December 17,
2024, using the IPRCC nomination
webform: https://
www.surveymonkey.com/r/IPRCCnomination-form
Dated: October 25, 2024.
Walter J. Koroshetz,
Director, National Institute of Neurological
Disorders and Stroke, National Institutes of
Health.
[FR Doc. 2024–25241 Filed 10–30–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
E:\FR\FM\31OCN1.SGM
31OCN1
]]>Agencies
[Federal Register Volume 89, Number 211 (Thursday, October 31, 2024)]
[Notices]
[Page 86830]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-25241]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke,
Interagency Pain Research Coordinating Committee Call for Committee
Membership Nominations
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (HHS) (Department)
has created the Interagency Pain Research Coordinating Committee
(IPRCC) and is seeking nominations for this committee.
DATES: Nominations are due by 5:00 p.m. ET on December 17, 2024.
ADDRESSES: Nominations must be submitted through the webform on the
IPRCC website: https://www.surveymonkey.com/r/IPRCC-nomination-form.
FOR FURTHER INFORMATION CONTACT: Leah Pogorzala, [email protected]
or 301-496-4228.
SUPPLEMENTARY INFORMATION: As specified in Public Law 111-148
(``Patient Protection and Affordable Care Act'') the Committee will:
(A) develop a summary of advances in pain care research supported
or conducted by the Federal agencies relevant to the diagnosis,
prevention, and treatment of pain and diseases and disorders associated
with pain;
(B) identify critical gaps in basic and clinical research on the
symptoms and causes of pain;
(C) make recommendations to ensure that the activities of the
National Institutes of Health and other Federal agencies are free of
unnecessary duplication of effort;
(D) make recommendations on how best to disseminate information on
pain care; and (e) make recommendations on how to expand partnerships
between public entities and private entities to expand collaborative,
cross-cutting research.
Membership on the committee will include six (6) non-Federal
members from among scientists, physicians, and other health
professionals and six (6) non-Federal members of the general public who
are representatives of leading research, advocacy, and service
organizations for individuals with pain-related conditions. Members
will serve overlapping three year terms. It is anticipated that the
committee will meet at least once a year.
The Department strives to ensure that the membership of HHS Federal
advisory committees is fairly balanced in terms of points of view
represented and the committee's function. Every effort is made to
ensure that the views of diverse ethnic and racial groups and people
with disabilities are represented on HHS Federal advisory committees,
and the Department therefore, encourages nominations of qualified
candidates from these groups. The Department also encourages geographic
diversity in the composition of the Committee. Appointment to this
Committee shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, disability, and cultural,
religious, or socioeconomic status.
The Department is soliciting nominations for non-federal members
from among scientists, physicians, and other health professionals and
for non-federal members of the public who represent a leading research,
advocacy, or service organization for people with pain-related
conditions. These candidates will be considered to fill positions
opened through completion of current member terms. Nominations are due
by 5:00 p.m. ET on December 17, 2024, using the IPRCC nomination
webform: https://www.surveymonkey.com/r/IPRCC-nomination-form
Dated: October 25, 2024.
Walter J. Koroshetz,
Director, National Institute of Neurological Disorders and Stroke,
National Institutes of Health.
[FR Doc. 2024-25241 Filed 10-30-24; 8:45 am]
BILLING CODE 4140-01-P
